Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside beta-triphosphates
  2. Dash, C.; Ahmadibeni, Y.; Hanley, M. J.; Pandhare, J.; Gotte, M.; Le Grice, S. F. J.; Parang, K.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jun; 21(12): 3519-3522.
  1. 2.   Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists
  2. Liu, F.; Stephen, A. G.; Waheed, A. A.; Freed, E. O.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(1): 318-321.
  1. 4.   Biotinylated biphenyl ketone-containing 2,4-dioxobutanoic acids designed as HIV-1 integrase photoaffinity ligands
  2. Zhao, X. Z.; Semenova, E. A.; Liao, C. Z.; Nicklaus, M.; Pommier, Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2006, Dec; 14(23): 7816-7825.
  1. 5.   Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: Application to the preparation of Tsg101-directed HIV-1 budding antagonists
  2. Liu, F.; Stephen, A. G.; Adamson, C. S.; Gousset, K.; Aman, M. J.; Freed, E. O.; Fisher, R. J.; Burke, T. R.
  3. Organic Letters. 2006, Oct; 8(22): 5165-5168.
  1. 6.   Design and synthesis of phosphonodifluoromethyl phenylalanine (F(2)Pmp): A useful phosphotyrosyl mimetic
  2. Burke, T. R.
  3. Current Topics in Medicinal Chemistry. 2006 6(14): 1465-1471.
  1. 7.   The search for novel drug leads for predominately antitumor therapies by utilizing mother nature's pharmacophoric libraries
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2005, MAR; 8(2): 207-227.
  1. 8.   Synthesis of gold nanoparticles bearing the Thomsen-Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen
  2. Svarovsky, S. A.; Szekely, Z.; Barchi, J. J.
  3. Tetrahedron-Asymmetry. 2005, JAN 24; 16(2): 587-598.
  1. 9.   Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide
  2. Kang, S. U.; Yang, G.; Li, W.; Zhang, Z. Y.; Burke, T. R.
  3. Chemistry & Biodiversity. 2004 1(4): 626-633.
  1. 10.   Phosphotyrosyl mimetics in the development of signal transduction inhibitors
  2. Burke, T. R.; Lee, K.
  3. Accounts of Chemical Research. 2003 36(6): 426-433.
  1. 11.   CD45 protein-tyrosine phosphatase inhibitor development
  2. Lee, K.; Burke, T. R.
  3. Current Topics in Medicinal Chemistry. 2003 3(7): 797-807.
  1. 12.   Design and synthesis of a beta-amino phosphotyrosyl mimetic suitably protected for peptide synthesis
  2. Lee, K.; Zhang, M. C.; Yang, D. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2002 12(23): 3399-3401.
  1. 13.   Synthesis and investigation of conformationally restricted analogues of lavendustin A as cytotoxic inhibitors of tubulin polymerization
  2. Mu, F. R.; Lee, D. J.; Pryor, D. E.; Hamel, E.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2002 45(21): 4774-4785.
  1. 14.   Current synthetic approaches to peptide and peptidomimetic cyclization
  2. Li, P.; Roller, P. P.; Xu, J. C.
  3. Current Organic Chemistry. 2002 6(5): 411-440.
  1. 15.   Synthesis, X-ray crystal structure and tubulin-binding properties of a benzofuran analogue of the potent cytotoxic agent combretastatin A4
  2. Banwell, M. G.; Flynn, B. L.; Willis, A. C.; Hamel, E.
  3. Australian Journal of Chemistry. 1999 52(8): 767-774.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel